Condition

SARS-CoV 2 (2)

COVID-19 (1)

Overall Status

Active, not recruiting (1)

Terminated (1)

Phase

phase 2 (2)

Sponsor

Johns Hopkins University (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Collaborator

Bloomberg Foundation (1)

National Center for Advancing Translational Science (NCATS) (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

State of Maryland (1)

Teva Pharmaceutical Industries, Ltd. (1)

United States Department of Defense (1)

Intervention

azithromycin (azithro) (1)

hydroxychloroquine (hcq) (1)

placebo for azithromycin (1)

placebo for hydroxychloroquine (1)

plasma from a volunteer donor (1)

sars-cov-2 convalescent plasma (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

SARS-CoV 2

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

SARS-CoV 2 Trial in United States (SARS-CoV-2 convalescent plasma, Plasma from a volunteer donor)

Active, not recruiting

SARS-CoV 2

SARS-CoV-2 convalescent plasma
Plasma from a volunteer donor

Birmingham, Alabama
+24 more

Jun 2, 2022

COVID-19, SARS-CoV 2 Trial in United States (Hydroxychloroquine (HCQ), Azithromycin (Azithro), Placebo for Hydroxychloroquine)

Terminated

Has Results

COVID-19
SARS-CoV 2

Hydroxychloroquine (HCQ)
+3 more

Birmingham, Alabama
+10 more

Nov 12, 2021